|

Screening and Secondary Prevention Rheumatic Heart Disease Study

RECRUITINGSponsored by National Institute of Cardiovascular Diseases, Pakistan
Actively Recruiting
SponsorNational Institute of Cardiovascular Diseases, Pakistan
Started2022-09-26
Est. completion2028-12-31
Eligibility
Age10 Years – 30 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05991219

Summary

After basic clinical screening including history and physical, Point of care ultrasound will be performed to look at Mitral, Aortic and Tricuspid Valves for regurgitation or stenosis. For patients with confirmed Rheumatic heart disease (RHD), treatment and referral depending on stage of disease. Antibiotic prescription could be shifted to community health workers delivering preventive medications via practical clinical algorithms, diagnostic tools, availability of appropriate antibiotics, and supportive supervision. Patients will have repeat imaging at 2 years and 5 years to look at the outcome of delayed progression of valve disease.

Eligibility

Age: 10 Years – 30 YearsHealthy volunteers accepted
Inclusion Criteria:

* Rural communities in Sindh

Exclusion Criteria:

* Refused to participate in the study

Conditions2

Heart DiseaseRheumatic Heart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.